share_log

NRx Pharmaceuticals Shares Are Trading Higher After the Company Announced a Statistically Significant Safety Advantage of NRX-101 Compared to the Standard of Care Comparator in Its Recently Completed Clinical Trial in Patients With Suicidal Bipolar...

NRx Pharmaceuticals Shares Are Trading Higher After the Company Announced a Statistically Significant Safety Advantage of NRX-101 Compared to the Standard of Care Comparator in Its Recently Completed Clinical Trial in Patients With Suicidal Bipolar...

nRx Pharmicals 股价上涨,此前该公司在最近完成的自杀性双相情感障碍患者临床试验中宣布,与护理比较标准相比,NRX-101 具有统计学上的显著安全优势...
Benzinga ·  05/06 22:18

NRx Pharmaceuticals Shares Are Trading Higher After the Company Announced a Statistically Significant Safety Advantage of NRX-101 Compared to the Standard of Care Comparator in Its Recently Completed Clinical Trial in Patients With Suicidal Bipolar Depression and Plans to Seek Accelerated Approval of NRX-101.

nRx Pharmicals在最近完成的针对自杀性双相抑郁症患者的临床试验中宣布,与护理比较标准相比,NRX-101 具有统计学上的显著安全优势,此后,该公司股价走高,并计划寻求加速批准 NRX-101。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发